Lista de obras - Christoph Correll - Dominio Público Uruguay

100 Olanzapine/Samidorphan for Schizophrenia: Weight Gain and Metabolic Outcomes in Phase 3 ENLIGHTEN-2 and Subsequent Long-Term, Open-Label Safety Study

scientific article published on 01 April 2020

104 Long-term Efficacy of Lurasidone in Antipsychotic-naïve vs. Antipsychotic-exposed Adolescents with Schizophrenia: Analysis of a Two-Year Study

scientific article published on 01 April 2020

130. Meta-Analysis of Tardive Dyskinesia Rates in Randomized Controlled Studies Comparing First- to Second-Generation Antipsychotics.

artículo científico publicado en 2017

186 Results From a 12-Month Open-label Safety Study of Lumateperone (ITI-007) in Patients with Stable Symptoms of Schizophrenia

scientific article published on 01 April 2020

24. The Clinical Development of Lumateperone (ITI-007) for the Treatment of Schizophrenia.

artículo científico publicado en 2017

67 Effects of Long-term Valbenazine on Psychiatric Status in Patients with Tardive Dyskinesia and a Primary Mood Disorder

A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes

artículo científico publicado en 2015

A Severity-Based Clinical Staging Model for the Psychosis Prodrome: Longitudinal Findings From the New York Recognition and Prevention Program

artículo científico publicado en 2017

A comparative meta-analysis of TEMPS scores across mood disorder patients, their first-degree relatives, healthy controls, and other psychiatric disorders

artículo científico publicado en 2016

A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls

artículo científico publicado en 2013

A meta-analysis of temperament and character dimensions in patients with mood disorders: Comparison to healthy controls and unaffected siblings

artículo científico publicado en 2016

A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy

artículo científico publicado en 2009

A new class of VMAT-2 inhibitors for tardive dyskinesia.

artículo científico publicado en 2017

A prospective study of hyperprolactinemia in children and adolescents treated with atypical antipsychotic agents

artículo científico publicado en 2004

A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design

scientific article published on 05 September 2019

A randomized, double-blind, placebo-controlled proof of concept study to evaluate samidorphan in the prevention of olanzapine-induced weight gain in healthy volunteers

artículo científico publicado en 2017

A review of physical activity correlates in patients with bipolar disorder

artículo científico publicado en 2012

A simulations approach for meta-analysis of genetic association studies based on additive genetic model

artículo científico publicado en 2018

A symptom combination predicting treatment-resistant schizophrenia - A strategy for real-world clinical practice

artículo científico publicado en 2020

A systematic meta-analysis of the association of Neuregulin 1 (NRG1), D-amino acid oxidase (DAO), and DAO activator (DAOA)/G72 polymorphisms with schizophrenia

artículo científico publicado en 2017

AACAP 2006 Research Forum--Advancing research in early-onset bipolar disorder: barriers and suggestions

artículo científico publicado en 2009

Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference

artículo científico publicado en 2019

Acanthosis nigricans during treatment with aripiprazole

artículo científico publicado en 2014

Acetylcholinesterase inhibitors and memantine in bipolar disorder: A systematic review and best evidence synthesis of the efficacy and safety for multiple disease dimensions

artículo científico publicado en 2016

Activating and Tranquilizing Effects of First-Time Treatment with Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Youth

artículo científico publicado en 2016

Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: a meta-analytic comparison of randomized controlled trials.

artículo científico publicado en 2012

Adaptation of a peer based online emotional support program as an adjunct to treatment for people with schizophrenia-spectrum disorders

scientific article published on 29 March 2016

Adapting to the impact of COVID-19 on mental health: an international perspective

artículo científico publicado en 2020

Adherence to guidelines for glucose assessment in starting second-generation antipsychotics

artículo científico publicado en 2014

Adjunctive minocycline in schizophrenia: what one well-conducted study can tell us (and what it can't)

artículo científico publicado en 2019

Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials

artículo científico publicado en 2013

Altered Signaling in CB1R-5-HT2AR Heteromers in Olfactory Neuroepithelium Cells of Schizophrenia Patients is Modulated by Cannabis Use

scientific article published on 06 April 2020

Altered intrinsic functional brain architecture in female patients with bulimia nervosa

artículo científico publicado en 2017

Ambiguous findings concerning potential advantages of depot antipsychotics: in search of clinical relevance

artículo científico

An International Society of Bipolar Disorders task force report: Precursors and prodromes of bipolar disorder

scientific article published on 18 September 2019

An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes

artículo científico publicado en 2019

Analgesic Effects of Alcohol: A Systematic Review and Meta-Analysis of Controlled Experimental Studies in Healthy Participants

artículo científico publicado en 2016

Annual Research Review: Prevention of psychosis in adolescents - systematic review and meta-analysis of advances in detection, prognosis and intervention

scientific article published on 14 September 2020

Antipsychotic Medication Treatment Patterns in Adult Depression.

artículo científico publicado en 2017

Antipsychotic Polypharmacy in Schizophrenia: Why Not?

scientific article published on 28 April 2020

Antipsychotic Use Trends in Youth With Autism Spectrum Disorder and/or Intellectual Disability: A Meta-Analysis.

artículo científico publicado en 2016

Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials

artículo científico publicado en 2010

Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis

scientific article published on February 2017

Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials

artículo científico publicado en 2008

Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: results from a nested case-control study

artículo científico publicado en 2011

Antipsychotic drugs and obesity

artículo científico publicado en 2010

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

artículo científico publicado en 2005

Antipsychotic polypharmacy: A survey study of prescriber attitudes, knowledge and behavior ⬇️

artículo científico publicado el 21 de marzo de 2011

Antipsychotic polypharmacy: a Japanese survey of prescribers' attitudes and rationales

artículo científico publicado en 2013

Antipsychotic use and risk of life-threatening medical events: umbrella review of observational studies

artículo científico publicado en 2019

Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naïve schizophrenia patients

artículo científico publicado en 2010

Antipsychotics for acute schizophrenia: making choices

artículo científico publicado en 2013

Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials

artículo científico publicado en 2013

Antipsychotics for primary alcohol dependence: a systematic review and meta-analysis of placebo-controlled trials

artículo científico publicado en 2013

Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns

scientific article published on 24 May 2009

Appraising the effectiveness of electrical and magnetic brain stimulation techniques in acute major depressive episodes: an umbrella review of meta-analyses of randomized controlled trials

scientific article published on 23 October 2020

Are antipsychotics effective for the treatment of anorexia nervosa? Results from a systematic review and meta-analysis

artículo científico publicado en 2012

Aripiprazole for the Treatment of Antipsychotic-Induced Hyperprolactinemia in an Adolescent Boy.

artículo científico publicado en 2016

Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study

artículo científico publicado en 2013

Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry

artículo científico publicado en 2013

Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies

artículo científico publicado en 2019

Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain

artículo científico publicado en 2012

Association between mental disorders and somatic conditions: protocol for an umbrella review

artículo científico publicado en 2020

Association of Antidepressant Use With Adverse Health Outcomes: A Systematic Umbrella Review

scientific article published on 02 October 2019

Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophrenia

artículo científico publicado en 2013

Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis

artículo científico publicado en 2016

Atypical antipsychotics: recent research findings and applications to clinical practice: Proceedings of a symposium presented at the 29th Annual European College of Neuropsychopharmacology Congress, 19 September 2016, Vienna, Austria

scientific article published on March 2017

Authors' reply

BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis

artículo científico publicado en 2014

Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled Trial.

artículo científico publicado en 2017

Benign Ethnic Neutropenia and Clozapine Use: A Systematic Review of the Evidence and Treatment Recommendations

artículo científico publicado en 2016

Biological treatment of acute agitation or aggression with schizophrenia or bipolar disorder in the inpatient setting

Bipolar Prodrome Symptom Scale - Abbreviated Screen for Patients: Description and validation

scientific article published on 12 February 2019

Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharma

scientific article published on 19 May 2020

Body mass index identified as an independent predictor of psychiatric readmission.

artículo científico publicado en 2014

Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis

artículo científico publicado en 2012

CNR1 gene and risk of the metabolic syndrome in patients with schizophrenia

artículo científico publicado en 2013

Can an early weight management program (WMP) prevent olanzapine (OLZ)-induced disturbances in body weight, blood glucose and lipid metabolism? Twenty-four- and 48-week results from a 6-month randomized trial

artículo científico publicado en 2011

Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents

artículo científico publicado en 2007

Cardiometabolic Adverse Effects and Its Predictors in Children and Adolescents With First-Episode Psychosis During Treatment With Quetiapine-Extended Release Versus Aripiprazole: 12-Week Results From the Tolerance and Effect of Antipsychotics in Chi

artículo científico publicado en 2019

Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study

artículo científico publicado en 2014

Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents

artículo científico publicado en 2009

Catechol-O-Methyltransferase (COMT) Val158Met Polymorphism and Eating Disorders: Data From a New Biobank and Meta-Analysis of Previously Published Studies.

artículo científico publicado en 2017

Change and dispersion of QT interval during treatment with quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: results from the TEA trial

artículo científico publicado en 2017

Changes in Telepsychiatry Regulations during the COVID-19 Pandemic: 17 Countries and Regions' Approaches to an Evolving Healthcare Landscape

artículo científico publicado en 2020

Characteristics and predictors of long-term institutionalization in patients with schizophrenia

artículo científico publicado en 2011

Characteristics, symptomatology and naturalistic treatment in individuals at-risk for bipolar disorders: baseline results in the first 180 help-seeking individuals assessed at the Dresden high-risk project

artículo científico publicado en 2013

Characterizing Treatment Effects of Valbenazine for Tardive Dyskinesia: Additional Results From the KINECT 3 Study

scientific article published on 18 December 2018

Clinical Characteristics and Predictors of Outcome of Schizophrenia-Spectrum Psychosis in Children and Adolescents: A Systematic Review

artículo científico publicado en 2016

Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia

scientific article published on 05 March 2019

Clinical characteristics and influence of childhood trauma on the prodrome of bipolar disorder

artículo científico publicado en 2015

Clinical predictors of therapeutic response to antipsychotics in schizophrenia

artículo científico publicado en 2014

Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia.

artículo científico publicado en 2019

Clinical risk factors for the development of tardive dyskinesia

artículo científico publicado en 2018

Clinical validation of the self-reported Glasgow Antipsychotic Side-effect Scale using the clinician-rated UKU side-effect scale as gold standard reference

scientific article published on 05 June 2020

Clozapine Combination and Augmentation Strategies in Patients With Schizophrenia -Recommendations From an International Expert Survey Among the Treatment Response and Resistance in Psychosis (TRRIP) Working Group

scientific article published on 18 May 2020

Clozapine and "high-dose" olanzapine in refractory early-onset schizophrenia: a 12-week randomized and double-blind comparison

artículo científico publicado en 2007

Clozapine and COVID-19: The authors respond

artículo científico publicado en 2020

Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012).

artículo científico publicado en 2015

Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition

artículo científico publicado en 2023

Cognitive functioning in individuals at ultra-high risk for psychosis, first-degree relatives of patients with psychosis and patients with first-episode schizophrenia

artículo científico publicado en 2016

Commentary on Robert Whitaker's viewpoint

scientific article published on 26 October 2020

Common use of high doses of antipsychotic medications in older Asian patients with schizophrenia (2001-2009).

artículo científico publicado en 2013

Comorbidity of chronic somatic diseases in patients with psychotic disorders and their influence on 4-year outcomes of integrated care treatment (ACCESS II study).

artículo científico publicado en 2017

Comparative effectiveness of risperidone long-acting injectable vs first-generation antipsychotic long-acting injectables in schizophrenia: results from a nationwide, retrospective inception cohort study

artículo científico publicado en 2014

Comparing clinical and neurocognitive features of the schizophrenia prodrome to the bipolar prodrome

artículo científico publicado en 2010

Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression

article

Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program

artículo científico publicado en 2015

Consensus statement on the use of clozapine during the COVID-19 pandemic

artículo científico publicado en 2020

Corrected QT changes during antipsychotic treatment of children and adolescents: a systematic review and meta-analysis of clinical trials

artículo científico

Correction to: Effectiveness of aripiprazole once-monthly in schizophrenia patients pretreated with oral aripiprazole: a 6-month, real-life non-interventional study

scholarly article published in BMC Psychiatry

Correction to: Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations

scientific article published on 12 September 2020

Correlates of Clozapine Use after a First Episode of Schizophrenia: Results From a Long-term Prospective Study

artículo científico publicado en 2016

Correlates of Subjective Caregiver Strain in Caregivers of Youth Evaluated in a Pediatric Psychiatric Emergency Room

artículo científico publicado en 2016

Corrigendum to "Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies" [Schizophr. Res. 174 (2016) 82-92]

scientific article published on 25 March 2017

Cost of antipsychotic polypharmacy in the treatment of schizophrenia

artículo científico publicado en 2008

Cost-Effectiveness of Comprehensive, Integrated Care for First Episode Psychosis in the NIMH RAISE Early Treatment Program

artículo científico publicado en 2016

Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications

artículo científico publicado en 2005

Could the Quick Inventory of Depressive Symptomatology-Self-Report (QIDS-SR) be used in depressed schizophrenia patients?

artículo científico publicado en 2014

Course of Psychosis in Schizophrenia With Alcohol Use Disorder: A Post Hoc Analysis of the Clinical Antipsychotic Trials of Intervention Effectiveness in Schizophrenia Phase 1 Study

scientific article published on 17 March 2020

Creativity in persons at-risk for bipolar disorder-A pilot study

article

Critical issues on the use of network meta-analysis in psychiatry

artículo científico publicado en 2014

Cultural Influences in Psychiatry-Reply

artículo científico publicado en 2020

DSM-5 Attenuated Psychosis Syndrome in Adolescents Hospitalized With Non-psychotic Psychiatric Disorders

artículo científico publicado en 2020

Decision making and antipsychotic medication treatment for youth with autism spectrum disorders: applying guidelines in the real world

artículo científico publicado en 2013

Decreased pain sensitivity among people with schizophrenia: a meta-analysis of experimental pain induction studies

artículo científico

Delayed identification and diagnosis of Huntington's disease due to psychiatric symptoms

artículo científico publicado en 2015

Demographic and Clinical Characteristics, Including Subsyndromal Symptoms Across Bipolar-Spectrum Disorders in Adolescents

artículo científico publicado en 2020

Demographic and clinical correlates of substance use disorders in first episode psychosis

artículo científico publicado en 2017

Depression, anxiety disorders, and metabolic syndrome in a population at risk for type 2 diabetes mellitus

artículo científico publicado en 2015

Determinants of poor dental care in patients with schizophrenia: a historical, prospective database study

artículo científico publicado en 2010

Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics

scientific article published on May 2011

Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis

artículo científico publicado en 2016

Diabetes risk potentially underestimated in youth and children receiving antipsychotics

artículo científico publicado en 2014

Diagnosis and treatment in the early illness phase of bipolar disorders

artículo científico publicado en 2008

Diagnostic stability in children and adolescents with bipolar disorder, a nationwide register-based study

scientific article published on 06 May 2020

Differential Risk of Increasing Psychotropic Polypharmacy Use in Children Diagnosed With ADHD as Preschoolers

artículo científico publicado en 2017

Differential effects of age at illness onset on verbal memory functions in antipsychotic-naïve schizophrenia patients aged 12-43 years

artículo científico publicado en 2020

Differentiation in the preonset phases of schizophrenia and mood disorders: evidence in support of a bipolar mania prodrome

artículo científico publicado en 2007

Digital Parent Training for Children with Disruptive Behaviors: Systematic Review and Meta-Analysis of Randomized Trials

artículo científico publicado en 2016

Digital Trajectories to Care in First-Episode Psychosis

scientific article published on 26 September 2018

Disparities in cancer screening in people with mental illness across the world versus the general population: prevalence and comparative meta-analysis including 4 717 839 people

scientific article published on 29 November 2019

Disturbing Lack of Early Intervention Studies in Bipolar Disorder-Reply

scientific article published on 01 November 2018

Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study

artículo científico publicado en 2010

Do antipsychotics increase diabetes risk in children and adolescents?

artículo científico publicado en 2014

Does a GLP-1 receptor agonist change glucose tolerance in patients treated with antipsychotic medications? Design of a randomised, double-blinded, placebo-controlled clinical trial

artículo científico publicado en 2014

Does antipsychotic polypharmacy increase the risk for metabolic syndrome?

artículo científico publicado en 2006

Dr Correll and Colleagues Reply.

artículo científico publicado en 2017

Dr. Nielsen and colleagues reply

artículo científico publicado en 2015

Drs Kane and Correll Reply

scientific article published on 16 June 2020

Duration of Untreated Psychosis in Community Treatment Settings in the United States

artículo científico publicado en 2015

Duration of attenuated positive and negative symptoms in individuals at clinical high risk: Associations with risk of conversion to psychosis and functional outcome

artículo científico publicado en 2016

Dysmetabolic Signals in "Metabolically Healthy" Obesity

artículo científico publicado en 2012

ECT augmentation of clozapine for clozapine-resistant schizophrenia: A meta-analysis of randomized controlled trials

artículo científico publicado en 2018

EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Me

article by Brendon Stubbs et al published October 2018 in European Psychiatry

Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review

artículo científico publicado en 2015

Early Non-Response to Antipsychotic Treatment in Schizophrenia: A Systematic Review and Meta-Analysis of Evidence-Based Management Options

artículo científico publicado en 2023

Early Prediction of Antipsychotic Response in Schizophrenia ⬇️

artículo científico publicado el 1 de noviembre de 2003

Early antipsychotic response to aripiprazole in adolescents with schizophrenia: predictive value for clinical outcomes

artículo científico publicado en 2013

Early detection and integrated care for adolescents and young adults with severe psychotic disorders: rationales and design of the Integrated Care in Early Psychosis Study (ACCESS III).

artículo científico publicado en 2016

Early identification and high-risk strategies for bipolar disorder

artículo científico publicado en 2007

Early nonresponse determined by the clinical global impressions scale predicts poorer outcomes in youth with schizophrenia spectrum disorders naturalistically treated with second-generation antipsychotics

artículo científico publicado en 2013

Early recognition centers for mental disorders - a complementary supply in the german health system

artículo científico publicado en 2013

Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trial.

artículo científico publicado en 2015

Early specific cognitive-behavioural psychotherapy in subjects at high risk for bipolar disorders: study protocol for a randomised controlled trial

artículo científico publicado en 2014

Early stages of bipolar disorder: characterization and strategies for early intervention

artículo científico publicado en 2015

Effect Size and Blinding in Lumateperone Trial-Reply

artículo científico publicado en 2020

Effect of Liraglutide Treatment on Prediabetes and Overweight or Obesity in Clozapine- or Olanzapine-Treated Patients With Schizophrenia Spectrum Disorder: A Randomized Clinical Trial.

artículo científico publicado en 2017

Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase Schizophrenia: A Randomized Clinical Trial

scientific article published on 15 July 2020

Effectiveness of Long-Acting Injectable vs Oral Antipsychotics in Patients With Schizophrenia: A Meta-analysis of Prospective and Retrospective Cohort Studies

artículo científico publicado en 2018

Effectiveness of Transdiagnostic Cognitive-Behavioral Psychotherapy Compared With Management as Usual for Youth With Common Mental Health Problems: A Randomized Clinical Trial

artículo científico publicado en 2020

Effectiveness of a cognitive behavioral weight management intervention in obese patients with psychotic disorders compared to patients with nonpsychotic disorders or no psychiatric disorders: results from a 12-month, real-world study

artículo científico publicado en 2012

Effectiveness of medications used to attenuate antipsychotic-related weight gain and metabolic abnormalities: a systematic review and meta-analysis

artículo científico publicado en 2010

Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study

artículo científico publicado en 2020

Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder

artículo científico publicado en 2015

Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial

artículo científico publicado en 2015

Efficacy and Safety of Lumateperone for Treatment of Schizophrenia: A Randomized Clinical Trial

scientific article published on 08 January 2020

Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia

artículo científico publicado en 2018

Efficacy and safety of blonanserin transdermal patch in patients with schizophrenia: A 6-week randomized, double-blind, placebo-controlled, multicenter study

scientific article published on 27 August 2019

Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis

artículo científico publicado en 2013

Efficacy and safety of once-monthly Risperidone ISM® in schizophrenic patients with an acute exacerbation

artículo científico publicado en 2020

Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons

scientific article published on 10 August 2010

Efficacy and tolerability of clozapine in Japanese patients with treatment-resistant schizophrenia: results from a 12-week, flexible dose study using raters masked to antipsychotic choice.

artículo científico publicado en 2012

Efficacy for Psychopathology and Body Weight and Safety of Topiramate-Antipsychotic Cotreatment in Patients With Schizophrenia Spectrum Disorders: Results From a Meta-Analysis of Randomized Controlled Trials

artículo científico publicado en 2016

Efficacy of Atypical Antipsychotics in the Management of Acute Agitation and Aggression in Hospitalized Patients with Schizophrenia or Bipolar Disorder: Results from a Systematic Review

artículo científico publicado en 2016

Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder

artículo científico publicado en 2017

Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder

artículo científico publicado en 2017

Efficacy of brexpiprazole in patients with acute schizophrenia: Review of three randomized, double-blind, placebo-controlled studies

artículo científico publicado en 2016

Efficacy of cognitive-behavioral group therapy in patients at risk for serious mental illness presenting with subthreshold bipolar symptoms: Results from a prespecified interim analysis of a multicenter, randomized, controlled study

scientific article published on 28 February 2020

Efficacy of pharmacologic and psychotherapeutic interventions in psychiatry: to talk or to prescribe: is that the question?

artículo científico publicado en 2014

Electroconvulsive therapy and its association with demographic and clinical characteristics in Chinese psychiatric patients

artículo científico

Elevated blood urea nitrogen and medical outcome of psychiatric inpatients

artículo científico publicado en 2014

Emerging drugs for schizophrenia: an update

artículo científico publicado en 2014

Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents

artículo científico publicado en 2006

Epidemiology, Prevention, and Assessment of Tardive Dyskinesia and Advances in Treatment

artículo científico publicado en 2017

Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics

artículo científico publicado en 2008

Ethical considerations for precision psychiatry: A roadmap for research and clinical practice

artículo científico publicado en 2022

European college of neuropsychopharmacology network on the prevention of mental disorders and mental health promotion (ECNP PMD-MHP)

scientific article published on 09 October 2019

Evaluating the Effect of the Changes in FDA Guidelines for Clozapine Monitoring

artículo científico publicado en 2017

Evaluation of akathisia in patients with schizophrenia, schizoaffective disorder, or bipolar I disorder: a post hoc analysis of pooled data from short- and long-term aripiprazole trials

artículo científico publicado en 2009

Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment tool

artículo científico publicado en 2020

Experts' recommendations for treating maladaptive aggression in youth.

artículo científico publicado en 2011

Exploration of Treatment-Resistant Schizophrenia Subtypes Based on a Survey of 204 US Psychiatrists

artículo científico publicado en 2019

Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients

artículo científico publicado en 2023

Extent, Time Course, and Moderators of Antipsychotic Treatment in Youth With Mood Disorders: Results of a Meta-Analysis and Meta-Regression Analyses

artículo científico publicado en 2017

F106. EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAïVE ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 6-WEEK, RANDOMIZED, PLACEBO-CONTROLLED STUDY

F119. MULTILEVEL ANALYSIS IMPROVES THE MODEL FIT OF THE DIMENSIONAL STRUCTURE OF THE PANSS IN PATIENTS WITH SCHIZOPHRENIA.

artículo científico publicado en 2018

F28. CLINICAL VALIDATION OF THE GLASGOW ANTIPSYCHOTIC SIDE EFFECT SCALE (GASS)

F46. LUMATEPERONE (ITI-007): FAVORABLE SAFETY PROFILE IN AN OPEN LABEL SAFETY SWITCHING STUDY FROM STANDARD-OF-CARE ANTIPSYCHOTIC THERAPY IN PATIENTS WITH SCHIZOPHRENIA.

artículo científico publicado en 2018

Findings of a U.S. national cardiometabolic screening program among 10,084 psychiatric outpatients

artículo científico publicado en 2010

First-episode psychosis: a window of opportunity for best practices

artículo científico publicado en 2007

Frequency and correlates of DSM-5 attenuated psychosis syndrome in a sample of adolescent inpatients with nonpsychotic psychiatric disorders

artículo científico publicado en 2015

Frequency and correlates of antipsychotic polypharmacy among patients with schizophrenia in Denmark: A nation-wide pharmacoepidemiological study

artículo científico publicado en 2015

Frequency and correlates of inappropriate pediatric psychiatric emergency room visits

artículo científico publicado en 2009

Frequency of hyperprolactinemia and its associations with demographic and clinical characteristics and antipsychotic medications in psychiatric inpatients in China

artículo científico publicado en 2013

Frequency of involuntary admissions and its associations with demographic and clinical characteristics in China

artículo científico

Frequency, characteristics and management of adolescent inpatient aggression

artículo científico publicado en 2013

Genomics and the future of pharmacotherapy in psychiatry

artículo científico publicado en 2007

Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: A systematic review and individual participant data meta-analysis

scientific article published on 07 October 2018

Glutamatergic agents for schizophrenia: current evidence and perspectives

artículo científico

High prevalence of prediabetes and metabolic abnormalities in overweight or obese schizophrenia patients treated with clozapine or olanzapine

artículo científico publicado en 2018

How can we improve antidepressant adherence in the management of depression? A targeted review and 10 clinical recommendations

artículo científico publicado en 2020

How mental health care should change as a consequence of the COVID-19 pandemic

artículo científico publicado en 2020

ITI-007 for the Treatment of Schizophrenia: A 4-Week Randomized, Double-Blind, Controlled Trial.

artículo científico publicado en 2015

ITI-007 in the treatment of schizophrenia: from novel pharmacology to clinical outcomes

artículo científico publicado en 2016

Identification of high-risk coronary heart disease patients receiving atypical antipsychotics: single low-density lipoprotein cholesterol threshold or complex national standard?

artículo científico publicado en 2008

Identifying patients and clinical scenarios for use of long-acting injectable antipsychotics - expert consensus survey part 1.

artículo científico publicado en 2018

Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far?

artículo científico

Impact of comprehensive treatment for first episode psychosis on substance use outcomes: A randomized controlled trial

scientific article published on 24 July 2018

Impact of neurocognition on social and role functioning in individuals at clinical high risk for psychosis.

artículo científico publicado en 2011

Impact of paliperidone palmitate one-month formulation on relapse prevention in patients with schizophrenia: A post-hoc analysis of a one-year, open-label study stratified by medication adherence.

artículo científico publicado en 2018

Impairment in Social Functioning differentiates youth meeting Ultra-High Risk for psychosis criteria from other mental health help-seekers: A validation of the Italian version of the Global Functioning: Social and Global Functioning: Role scales

artículo científico publicado en 2017

Impairments in Negative Facial Emotion Recognition in Chinese Schizophrenia Patients Detected With a Newly Designed Task

artículo científico publicado en 2015

Improving early recognition and intervention in people at increased risk for the development of bipolar disorder: study protocol of a prospective-longitudinal, naturalistic cohort study (Early-BipoLife)

scientific article published on 01 July 2020

Improving metabolic parameters of antipsychotic child treatment (IMPACT) study: rationale, design, and methods

artículo científico publicado en 2013

Incidence of tardive dyskinesia with risperidone or olanzapine in the elderly: results from a 2-year, prospective study in antipsychotic-naïve patients

artículo científico publicado en 2011

Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia

artículo científico publicado en 2023

Inflammatory cytokines and anorexia nervosa: A meta-analysis of cross-sectional and longitudinal studies

article

Initiating/maintaining long-acting injectable antipsychotics in schizophrenia/schizoaffective or bipolar disorder - expert consensus survey part 2.

artículo científico publicado en 2018

Insomnia in Adults With Chronic Hepatitis B, Liver Failure, and Cirrhosis: A Case-Control Study

artículo científico publicado en 2015

Insomnia in older adults with chronic obstructive pulmonary disease (COPD) in Hong Kong: a case-control study

artículo científico publicado en 2013

Insulin secretion in patients receiving clozapine, olanzapine, quetiapine and risperidone

artículo científico publicado en 2012

Iron homeostasis alterations and risk for akathisia in patients treated with antipsychotics: A systematic review and meta-analysis of cross-sectional studies

scientific article published on 19 May 2020

Is Pain Perception Altered in People With Depression? A Systematic Review and Meta-Analysis of Experimental Pain Research

artículo científico publicado en 2016

Is Transcultural Psychiatry Possible?

artículo científico publicado en 2019

Keeping up with the therapeutic advances in schizophrenia: a review of novel and emerging pharmacological entities

artículo científico publicado en 2019

Knowledge of Psychiatric Nurses About the Potentially Lethal Side-Effects of Clozapine

artículo científico publicado en 2015

Lack of association between translin-associated factor X gene (TSNAX) and methamphetamine dependence in the Japanese population

artículo científico publicado en 2011

Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality

artículo científico publicado en 2009

Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials

artículo científico publicado en 2016

Lifestyle Interventions for Weight Management in People with Serious Mental Illness: A Systematic Review with Meta-Analysis, Trial Sequential Analysis, and Meta-Regression Analysis Exploring the Mediators and Moderators of Treatment Effects

artículo científico publicado en 2019

Liraglutide for the Treatment of Antipsychotic Drug-Induced Weight Gain-Reply

artículo científico publicado en 2017

Lithium Exposure During Pregnancy and the Postpartum Period: A Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes

scientific article published on 18 October 2019

Long-Acting Injectable Antipsychotics: Where Do They Fit in the Treatment Plan?

artículo científico publicado en 2018

Long-Term Remission With Cariprazine Treatment in Patients With Schizophrenia: A Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Trial

artículo científico publicado en 2019

Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies

artículo científico publicado en 2013

Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials

scientific article published on 17 December 2012

Long-term effectiveness of oral second-generation antipsychotics in patients with schizophrenia and related disorders: a systematic review and meta-analysis of direct head-to-head comparisons

artículo científico publicado en 2019

Long-term outcome of early-onset compared to adult-onset schizophrenia: A nationwide Danish register study

artículo científico publicado en 2020

Long-term safety and effectiveness of lurasidone in schizophrenia: a 22-month, open-label extension study

artículo científico publicado en 2016

Longitudinal course of depressive, anxiety and post-traumatic stress disorder symptoms after heart surgery: a meta-analysis of 94 studies

artículo científico publicado en 2020

Longitudinal outcomes in pediatric- and adult-onset bipolar patients compared to healthy and schizophrenia controls

artículo científico publicado en 2019

Low Hemoglobin Levels and Risk of Developing Depression in the Elderly: Results From the Prospective PRO.V.A. Study.

artículo científico publicado en 2016

Low Incidence of Neuroleptic Malignant Syndrome Associated With Paliperidone Palmitate Long-Acting Injectable: A Database Report and Case Study

Low-density lipoprotein cholesterol in patients treated with atypical antipsychotics: missed targets and lost opportunities

scientific article published on 06 March 2007

Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies

artículo científico publicado en 2004

Management of Patients With Severe Mental Illness During the Coronavirus Disease 2019 Pandemic

artículo científico publicado en 2020

Management of antipsychotic-related weight gain

artículo científico publicado en 2010

Markers of inflammation in schizophrenia: association vs. causation

artículo científico publicado en 2014

Measurement-Based Care Versus Standard Care for Major Depression: A Randomized Controlled Trial With Blind Raters

artículo científico publicado en 2015

Measuring movements in adolescents with psychosis using the Microsoft Kinect sensor: a pilot study exploring a new tool for assessing aspects of antipsychotic-induced parkinsonism

scientific article published on 07 January 2020

Medical outcome of psychiatric inpatients with admission hyponatremia

artículo científico publicado en 2012

Metabolic Monitoring Rates of Youth Treated with Second-Generation Antipsychotics in Usual Care: Results of a Large US National Commercial Health Plan

artículo científico publicado en 2019

Metabolic and cardiovascular adverse effects associated with antipsychotic drugs

artículo científico

Metabolic effects of treatment with atypical antipsychotics

artículo científico publicado en 2004

Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators

artículo científico publicado en 2013

Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs.

artículo científico publicado en 2006

Metformin add-on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trial

artículo científico publicado en 2020

Metformin for antipsychotic-related weight gain and metabolic abnormalities: when, for whom, and for how long?

artículo científico publicado en 2013

Mid-term and long-term efficacy and effectiveness of antipsychotic medications for schizophrenia: a data-driven, personalized clinical approach

artículo científico publicado en 2011

Mitigation of Olanzapine-Induced Weight Gain With Samidorphan, an Opioid Antagonist: A Randomized Double-Blind Phase 2 Study in Patients With Schizophrenia

artículo científico publicado en 2019

Mobility for All?

article

Mortality risk of antipsychotic augmentation for adult depression

scientific article published on 30 September 2020

National Patterns of Commonly Prescribed Psychotropic Medications to Young People

artículo científico publicado en 2018

National trends in second-generation antipsychotic augmentation for nonpsychotic depression.

artículo científico publicado en 2014

National trends in the mental health care of children, adolescents, and adults by office-based physicians

artículo científico publicado en 2014

National trends in the office-based treatment of children, adolescents, and adults with antipsychotics

artículo científico publicado en 2012

Negative Symptoms in Schizophrenia: A Review and Clinical Guide for Recognition, Assessment, and Treatment

scientific article published on 21 February 2020

Network analysis of the relationship between depressive symptoms, demographics, nutrition, quality of life and medical condition factors in the Osteoarthritis Initiative database cohort of elderly North-American adults with or at risk for osteoarthr

artículo científico publicado en 2019

Network analysis of the relationship between depressive symptoms, demographics, nutrition, quality of life and medical condition factors in the Osteoarthritis Initiative database cohort of elderly North-American adults with or at risk for osteoarthr

scientific article published on 08 March 2019

Neuromotor Adverse Effects in 342 Youth During 12 Weeks of Naturalistic Treatment With 5 Second-Generation Antipsychotics

artículo científico publicado en 2015

Neuropsychological Test Performance to Enhance Identification of Subjects at Clinical High Risk for Psychosis and to Be Most Promising for Predictive Algorithms for Conversion to Psychosis: A Meta-Analysis

artículo científico publicado en 2017

No significant association between SIRT1 gene and methamphetamine-induced psychosis in the Japanese population

artículo científico publicado en 2011

Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies

scientific article published on October 2013

Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia

artículo científico publicado en 2004

O11.5. EFFECTIVENESS OF COORDINATED SPECIALTY CARE FOR EARLY PSYCHOSIS.

artículo científico publicado en 2018

O12.1. CARDIOMETABOLIC ADVERSE EFFECTS AND ITS PREDICTORS IN CHILDREN AND ADOLESCENTS WITH FIRST-EPISODE PSYCHOSIS DURING TREATMENT WITH QUETIAPINE-ER VERSUS ARIPIPRAZOLE: 12-WEEK RESULTS: FROM THE TEA TRIAL

article by Gjessing Jensen Karsten et al published 9 April 2019 in Schizophrenia Bulletin

O5.2. LONG-TERM OUTCOME OF EARLY-ONSET SCHIZOPHRENIA

O5.5. PSYCHOTIC RELAPSE DURING MAINTENANCE ANTIPSYCHOTIC TREATMENT: A NATIONWIDE STUDY

O7.2. BREAKTHROUGH ON ANTIPSYCHOTIC MAINTENANCE MEDICATION IN A CLINICAL COHORT.

artículo científico publicado en 2018

Obesity and coronary risk in patients treated with second-generation antipsychotics ⬇️

artículo científico publicado el 12 de diciembre de 2010

Olanzapine Plus Samidorphan (ALKS 3831) in Schizophrenia and Comorbid Alcohol Use Disorder: A Phase 2, Randomized Clinical Trial

artículo científico publicado en 2020

One-Year Follow-up on Liraglutide Treatment for Prediabetes and Overweight/Obesity in Clozapine- or Olanzapine-Treated Patients

artículo científico publicado en 2018

One-year incidence rates of tardive dyskinesia in children and adolescents treated with second-generation antipsychotics: a systematic review

artículo científico publicado en 2007

Optimizing Treatment Choices to Improve Adherence and Outcomes in Schizophrenia

scientific article published on 17 September 2019

Oral Aripiprazole as Maintenance Treatment in Adolescent Schizophrenia: Results From a 52-Week, Randomized, Placebo-Controlled Withdrawal Study

artículo científico publicado en 2017

Osteoporosis and fracture risk in people with schizophrenia

artículo científico publicado en 2012

Outcome of Youth with Early-Phase Schizophrenia-Spectrum Disorders and Psychosis Not Otherwise Specified Treated with Second-Generation Antipsychotics: 12 Week Results from a Prospective, Naturalistic Cohort Study

artículo científico publicado en 2015

Outcomes of Neuroleptic Malignant Syndrome With Depot Versus Oral Antipsychotics: A Systematic Review and Pooled, Patient-Level Analysis of 662 Case Reports

scientific article published on 24 November 2020

Overview of short- and long-term tolerability and safety of brexpiprazole in patients with schizophrenia

artículo científico publicado en 2016

Oxidative Stress and Antioxidant Levels in Patients with Anorexia Nervosa after Oral Re-alimentation: A Systematic Review and Exploratory Meta-analysis

artículo científico

Oxidative stress and antioxidant levels in patients with anorexia nervosa: A systematic review and exploratory meta-analysis

artículo científico

Oxidative stress and antioxidant parameters in patients with major depressive disorder compared to healthy controls before and after antidepressant treatment: results from a meta-analysis

artículo científico publicado en 2015

Oxidative stress parameters and antioxidants in patients with bipolar disorder: Results from a meta-analysis comparing patients, including stratification by polarity and euthymic status, with healthy controls

artículo científico publicado en 2020

PM385. Long-term safety of brexpiprazole (OPC-34712) in schizophrenia: results from two 52-week open-label studies.

artículo científico publicado en 2016

PM421. Efficacy and safety of brexpiprazole (OPC-34712) in acute schizophrenia: a pooled analysis of two pivotal studies.

artículo científico publicado en 2016

Pain perception in Parkinson's disease: A systematic review and meta-analysis of experimental studies

artículo científico publicado en 2017

Past and Present Progress in the Pharmacologic Treatment of Schizophrenia ⬇️

artículo científico publicado el 1 de septiembre de 2010

Patches: Established and Emerging Transdermal Treatments in Psychiatry

scientific article published on 16 July 2019

Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists

artículo científico publicado en 2019

Perfectionism related to self-reported insomnia severity, but not when controlled for stress and emotion regulation

artículo científico publicado en 2015

Performance improvement CME: managing schizophrenia

scientific article published on 01 October 2011

Personal stigma in schizophrenia spectrum disorders: a systematic review of prevalence rates, correlates, impact and interventions

artículo científico publicado en 2013

Pharmacoepidemiology of antipsychotic use in youth with ADHD: trends and clinical implications

artículo científico publicado en 2013

Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis

artículo científico publicado en 2016

Pharmacogenetics of antipsychotic-induced weight gain

artículo científico publicado en 2004

Pharmacokinetics of venlafaxine in treatment responders and non-responders: a retrospective analysis of a large naturalistic database

scientific article published on 09 April 2019

Pharmacologic treatment of schizophrenia

artículo científico publicado en 2010

Pharmacological management of bipolar disorder in a youth with diabetes

artículo científico publicado en 2007

Pharmacological treatment of hyperactive delirium in people with COVID-19: rethinking conventional approaches

scientific article published on 20 July 2020

Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care ⬇️

artículo científico publicado el 1 de febrero de 2011

Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.

artículo científico publicado en 2011

Physical multimorbidity and psychosis: comprehensive cross sectional analysis including 242,952 people across 48 low- and middle-income countries

artículo científico publicado en 2016

Polypharmacy in Youth Treated With Antipsychotics: Do Antidepressants or Stimulants Add to the Risk for Type 2 Diabetes?

artículo científico publicado en 2017

Poor Sleep Is Related to Lower Emotional Competence Among Adolescents

artículo científico publicado en 2015

Practical considerations for managing breakthrough psychosis and symptomatic worsening in patients with schizophrenia on long-acting injectable antipsychotics

scientific article published on 27 December 2018

Prediabetes in patients treated with antipsychotic drugs

artículo científico publicado en 2011

Prediabetic increase in hemoglobin A1c compared with impaired fasting glucose in patients receiving antipsychotic drugs

artículo científico publicado en 2012

Prediction Analysis for Transition to Schizophrenia in Individuals at Clinical High Risk for Psychosis: The Relationship of DAO, DAOA, and NRG1 Variants with Negative Symptoms and Cognitive Deficits

artículo científico publicado en 2017

Prediction of functional outcome in individuals at clinical high risk for psychosis

artículo científico publicado en 2013

Predictors of clozapine response in patients with treatment-refractory schizophrenia: results from a Danish Register Study

artículo científico publicado en 2012

Predictors of insulin resistance in the obese with metabolic syndrome

artículo científico publicado en 2010

Predictors of psychosis breakthrough during 24 months of long-acting antipsychotic maintenance treatment in first episode schizophrenia

scientific article published on 22 November 2019

Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia

artículo científico publicado en 2008

Premature Mortality and Schizophrenia-The Need to Heal Right From the Start

artículo científico publicado en 2016

Prescribing of psychotropic medications to children and adolescents: quo vadis?

artículo científico publicado en 2013

Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study

artículo científico publicado en 2014

Pretreatment Cardiometabolic Status in Youth With Early-Onset Psychosis: Baseline Results From the TEA Trial.

artículo científico

Prevalence and correlates of antipsychotic polypharmacy in children and adolescents receiving antipsychotic treatment

artículo científico publicado en 2014

Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.

artículo científico publicado en 2012

Prevalence and correlates of seclusion and restraint use in children and adolescents: a systematic review ⬇️

artículo científico publicado el 5 de febrero de 2011

Prevalence of Catatonia and Its Moderators in Clinical Samples: Results from a Meta-analysis and Meta-regression Analysis.

artículo científico publicado en 2017

Prevalence of aggression in hospitalized patients with schizophrenia in China: A meta-analysis

artículo científico

Prevalence of nurses' smoking habits in psychiatric and general hospitals in China

artículo científico publicado en 2013

Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls

artículo científico publicado en 2017

Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention

artículo científico publicado en 2020

Primum non nocere: balancing the risks and benefits of prescribing psychotropic medications for youth with bipolar disorder

artículo científico publicado en 2010

Proceedings and data from The Schizophrenia Summit: a critical appraisal to improve the management of Schizophrenia.

artículo científico publicado en 2009

Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis

artículo científico publicado en 2015

Progressive muscle relaxation in persons with schizophrenia: a systematic review of randomized controlled trials

artículo científico publicado en 2012

Prospective memory performance in non-psychotic first-degree relatives of patients with schizophrenia: a controlled study

artículo científico publicado en 2014

Prospective study of adolescents with subsyndromal psychosis: characteristics and outcome

artículo científico publicado en 2005

Psychological well-being and mental health recovery in the NIMH RAISE early treatment program

artículo científico publicado en 2016

Psychopharmacological Treatment in the RAISE-ETP Study: Outcomes of a Manual and Computer Decision Support System Based Intervention

artículo científico publicado en 2017

Psychosis Prevention: A Modified Clinical High Risk Perspective From the Recognition and Prevention (RAP) Program

scientific article published on 05 June 2015

Psychosis relapse during treatment with long-acting injectable antipsychotics in individuals with schizophrenia-spectrum disorders: an individual participant data meta-analysis

scientific article published on 01 September 2020

Psychotherapeutic interventions in individuals at risk of developing bipolar disorder: a systematic review

artículo científico

QT interval duration and dispersion in children and adolescents treated with ziprasidone

artículo científico publicado en 2011

QTc prolongation in schizophrenia patients in Asia: clinical correlates and trends between 2004 and 2008/2009.

artículo científico publicado en 2015

Quality of life in older patients with chronic obstructive pulmonary disease (COPD) in Hong Kong: a case-control study

artículo científico publicado en 2014

Quantifying clinical relevance in the treatment of schizophrenia

artículo científico publicado en 2011

Quetiapine extended release versus aripiprazole in children and adolescents with first-episode psychosis: the multicentre, double-blind, randomised tolerability and efficacy of antipsychotics (TEA) trial

artículo científico publicado en 2017

Quetiapine versus aripiprazole in children and adolescents with psychosis--protocol for the randomised, blinded clinical Tolerability and Efficacy of Antipsychotics (TEA) trial

artículo científico publicado en 2014

Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives

artículo científico publicado en 2011

Ranking Antipsychotics for Efficacy and Safety in Schizophrenia

scientific article published on 06 November 2019

Rapid clozapine titration in treatment-refractory bipolar disorder

artículo científico publicado en 2014

Rare copy number variants in individuals at clinical high risk for psychosis: Enrichment of synaptic/brain-related functional pathways

scientific article published on 19 November 2019

Rates and predictors of one-year antipsychotic treatment discontinuation in first-episode schizophrenia: Results from an open-label, randomized, "real world" clinical trial

scientific article published on 24 January 2019

Rational use of generic psychotropic drugs

artículo científico publicado en 2013

Real-world effectiveness of clozapine in patients with bipolar disorder: results from a 2-year mirror-image study

artículo científico publicado en 2012

Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs

artículo científico publicado en 2012

Recognition of bipolar disorder type I before the first manic episode: challenges and developments.

artículo científico publicado en 2013

Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents

artículo científico publicado en 2006

Rejoinder to rejoinder to commentary

scientific article published on 21 December 2020

Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized, controlled trials.

artículo científico publicado en 2003

Relationship between nicotine dependence and the endophenotype-related trait of cognitive function but not acoustic startle reponses in Japanese patients with schizophrenia

artículo científico publicado en 2013

Research in people with psychosis risk syndrome: a review of the current evidence and future directions

artículo científico publicado en 2010

Response to Bartoli et al

article

Review: most antipsychotic drugs more than double the prolactin levels in children and adolescents

artículo científico

Review: quetiapine monotherapy improves response and remission compared with placebo in generalised anxiety disorder

artículo científico publicado en 2011

Revisiting the Abnormal Involuntary Movement Scale: Proceedings From the Tardive Dyskinesia Assessment Workshop

artículo científico publicado en 2018

Rhythmic low-field magnetic stimulation may improve depression by increasing brain-derived neurotrophic factor

artículo científico publicado en 2018

Risk and protective factors for mental disorders with onset in childhood/adolescence: an umbrella review of published meta-analyses of observational longitudinal studies

scientific article published on 12 September 2020

Risk constellations prior to the development of bipolar disorders: rationale of a new risk assessment tool

artículo científico

Risk factors for medical deterioration of psychiatric inpatients: opportunities for early recognition and prevention

artículo científico

Risk of cardiovascular disease morbidity and mortality in frail and pre-frail older adults: Results from a meta-analysis and exploratory meta-regression analysis.

artículo científico publicado en 2017

Risk of diabetes in children and adolescents exposed to antipsychotics: a nationwide 12-year case-control study.

artículo científico publicado en 2014

Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis

artículo científico publicado en 2015

Role of social media and the Internet in pathways to care for adolescents and young adults with psychotic disorders and non-psychotic mood disorders

artículo científico publicado en 2015

S129. DOES TREATMENT RESISTANT SCHIZOPHRENIA PRESENT A CHARACTERISTIC SYMPTOMATIC SIGNATURE?

artículo científico publicado en 2018

S27. RELIABILITY OF SCHIZOPHRENIA DIAGNOSES IN CHILDREN AND ADOLESCENTS IN DENMARK.

artículo científico publicado en 2018

S31. RELATIONSHIP BETWEEN TIMING OF RELAPSE AND PLASMA DRUG LEVELS FOLLOWING DISCONTINUATION OF CARIPRAZINE TREATMENT IN PATIENTS WITH SCHIZOPHRENIA

S44. LUMATEPERONE (ITI-007) FOR THE TREATMENT OF SCHIZOPHRENIA: PLACEBO-CONTROLLED CLINICAL TRIALS AND AN OPEN-LABEL SAFETY SWITCHING STUDY.

artículo científico publicado en 2018

S48. INTER-RATER RELIABILITY OF PANSS-6 SCHIZOPHRENIA SEVERITY RATINGS OBTAINED USING THE SIMPLIFIED NEGATIVE AND POSITIVE SYMPTOMS INTERVIEW (SNAPSI).

artículo científico publicado en 2018

S98. THE RELATIONSHIP BETWEEN CARDIOVASCULAR RISK FACTORS AND COGNITIVE IMPAIRMENT IN PEOPLE WITH SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS.

artículo científico publicado en 2018

SA114. Lurasidone for the Treatment of Adolescent Patients With Schizophrenia: Effect on PANSS Subscales.

artículo científico publicado en 2017

SA14. Long-Term Remission With Cariprazine Treatment in Patients With Schizophrenia: A Post Hoc Analysis of a Randomized, Double-Blind, Placebo-Controlled, Relapse Prevention Trial.

artículo científico publicado en 2017

SU1. Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis.

artículo científico publicado en 2017

Safety and Effectiveness of Lurasidone in Adolescents with Schizophrenia: Results of a 2-Year, Open-Label Extension Study

scientific article published on 20 October 2020

Safety and tolerability of antidepressant co-treatment in acute major depressive disorder: results from a systematic review and exploratory meta-analysis

artículo científico

Safety and tolerability of antipsychotic co-treatment in patients with schizophrenia: results from a systematic review and meta-analysis of randomized controlled trials

artículo científico publicado en 2016

Safety and tolerability of antipsychotic polypharmacy

artículo científico publicado en 2012

Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis

artículo científico

Safety and tolerability of long-acting injectable versus oral antipsychotics: A meta-analysis of randomized controlled studies comparing the same antipsychotics

artículo científico publicado en 2016

Safety of 80 antidepressants, antipsychotics, anti-attention-deficit/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects

scientific article published on 01 June 2020

Safety of Psychotropic Medications in People With COVID-19: Evidence Review and Practical Recommendations

scientific article published on 01 October 2020

Safety of psychotropic medications in people with COVID-19: evidence review and practical recommendations

scientific article published on 15 July 2020

Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review

artículo científico publicado en 2017

Schizophrenia

article

Schizophrenia relapse after stopping olanzapine treatment during pregnancy: a case report

artículo científico publicado en 2014

Schizophrenia: mechanism of action of current and novel treatments

artículo científico

Second-generation antipsychotic use in children and adolescents: a six-month prospective cohort study in drug-naïve patients

artículo científico publicado en 2014

Second-generation antipsychotic-associated diabetes mellitus and diabetic ketoacidosis: mechanisms, predictors, and screening need.

artículo científico publicado en 2009

Self-Reported and Interviewer-Rated Oral Health in Patients With Schizophrenia, Bipolar Disorder, and Major Depressive Disorder

artículo científico publicado en 2014

Serotonin 6 receptor gene and schizophrenia: case-control study and meta-analysis

artículo científico publicado en 2012

Sex and body weight are major determinants of venlafaxine pharmacokinetics

artículo científico publicado en 2018

Smoking in male patients with schizophrenia in China: A meta-analysis

artículo científico

Social and functional outcomes with two doses of aripiprazole lauroxil vs placebo in patients with schizophrenia: a post-hoc analysis of a 12-week phase 3 efficacy study

artículo científico publicado en 2019

Successful switching of patients with acute schizophrenia from another antipsychotic to brexpiprazole: comparison of clinicians' choice of cross-titration schedules in a post hoc analysis of a randomized, double-blind, maintenance treatment study

scientific article published on 01 October 2019

Sudden cardiac death in young adults with previous hospital-based psychiatric inpatient and outpatient treatment: a nationwide cohort study from Denmark

artículo científico publicado en 2015

Sudden deaths in psychiatric patients

artículo científico publicado en 2011

Sudden unexpected death in schizophrenia: autopsy findings in psychiatric inpatients

artículo científico

Suicidal ideation and suicide attempts in children and adolescents with bipolar disorder: a systematic review of prevalence and incidence rates, correlates, and targeted interventions

artículo científico publicado en 2013

Suicidality and hospitalization as cause and outcome of pediatric psychiatric emergency room visits

artículo científico publicado en 2014

Systematic review and exploratory meta-analysis of the efficacy, safety, and biological effects of psychostimulants and atomoxetine in patients with schizophrenia or schizoaffective disorder

scientific article published on 01 October 2019

Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia

artículo científico publicado en 2017

T22. CLINICAL VALIDATION OF THE SIX-ITEM POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS-6)

T232. EFFICACY AND SAFETY OF ANTIDEPRESSANT AUGMENTATION OF ANTIPSYCHOTICS IN SCHIZOPHRENIA.

artículo científico publicado en 2018

T234. BREAKTHROUGH ON ANTIPSYCHOTIC MAINTENANCE MEDICATION: A STUDY-LEVEL META-ANALYSIS AND META-REGRESSION ANALYSIS.

artículo científico publicado en 2018

T45. THE NEW YORK ASSESSMENT OF ADVERSE COGNITIVE EFFECTS OF NEUROPSYCHIATRIC TREATMENT (NY-AACENT): INITIAL VALIDATION FINDINGS

T63. EXPLORING NEW APPROACHES TO PARSE THE CLINICAL HETEROGENEITY IN SCHIZOPHRENIA BY STRUCTURE EQUATION MODELING

Tardive Dyskinesia Prevalence in the Period of Second-Generation Antipsychotic Use: A Meta-Analysis

artículo científico publicado en 2017

Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis

article by Maren Carbon et al published October 2018 in World Psychiatry

Technology-Assisted Parent Training Programs for Children and Adolescents With Disruptive Behaviors: A Systematic Review.

artículo científico publicado en 2017

Temperament and prodromal symptoms prior to first manic/hypomanic episodes: results from a pilot study

artículo científico publicado en 2014

Termination of clozapine treatment due to medical reasons: when is it warranted and how can it be avoided?

artículo científico publicado en 2013

The Bipolar Prodrome Symptom Interview and Scale-Prospective (BPSS-P): description and validation in a psychiatric sample and healthy controls.

artículo científico publicado en 2014

The Bipolar Prodrome: Meta-Analysis of Symptom Prevalence Prior to Initial or Recurrent Mood Episodes

artículo científico publicado en 2016

The CLOCK gene and mood disorders: a case-control study and meta-analysis

artículo científico publicado en 2011

The Effects of Valbenazine in Participants with Tardive Dyskinesia: Results of the 1-Year KINECT 3 Extension Study.

artículo científico publicado en 2017

The Importance of Second-Generation Antipsychotic-Related Weight Gain and Adherence Barriers in Youth with Bipolar Disorders: Patient, Parent, and Provider Perspectives

scientific article published on 19 May 2020

The International Society for Bipolar Disorders Task Force report on pediatric bipolar disorder: Knowledge to date and directions for future research.

artículo científico publicado en 2017

The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness

scientific article published on 16 July 2019

The Neurobiology of Treatment-Resistant Schizophrenia: Paths to Antipsychotic Resistance and A Roadmap for Future Research

scientific article published on 01 October 2020

The QTc interval and its dispersion in patients receiving two atypical antipsychotics

scientific article published on 20 June 2008

The RAISE early treatment program for first-episode psychosis: background, rationale, and study design

artículo científico

The Role of Clozapine in Treatment-Resistant Schizophrenia

artículo científico publicado en 2016

The Use of Long-Acting Injectable Antipsychotics in Schizophrenia: Evaluating the Evidence

artículo científico publicado en 2016

The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses

article

The assessment of "prodromal schizophrenia": unresolved issues and future directions

artículo científico publicado en 2003

The association between smoking prevalence and eating disorders: a systematic review and meta-analysis

artículo científico publicado en 2016

The bipolar disorder prodrome revisited: Is there a symptomatic pattern?

artículo científico publicado en 2013

The field of schizophrenia: strengths, weaknesses, opportunities, and threats

artículo científico publicado en 2011

The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials

article

The impact of prolactin-raising antipsychotics on bone mineral density in patients with schizophrenia: findings from a longitudinal observational cohort

artículo científico publicado en 2013

The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research

scientific article published on 07 January 2020

The prevalence and moderators of clinical pain in people with schizophrenia: a systematic review and large scale meta-analysis

artículo científico publicado en 2014

The relationship between acoustic startle response measures and cognitive functions in Japanese patients with schizophrenia

artículo científico publicado en 2012

The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia

artículo científico publicado en 2020

The schizophrenia prodrome revisited: a neurodevelopmental perspective

scientific article published on 01 January 2003

The serotonin 1A receptor gene confer susceptibility to mood disorders: results from an extended meta-analysis of patients with major depression and bipolar disorder

artículo científico

The significance of at-risk or prodromal symptoms for bipolar I disorder in children and adolescents

artículo científico publicado en 2013

The validity of the schizophrenia diagnosis in the Danish Psychiatric Central Research Register is good

artículo científico publicado en 2013

Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia

artículo científico publicado en 2014

Translation and adaptation of the Bipolar Prodrome Symptom Scale-Retrospective: Patient Version to Brazilian portuguese.

artículo científico publicado en 2013

Treatment models and designs for intervention research during the psychotic prodrome

artículo científico publicado en 2003

Treatment of adolescents with early-onset schizophrenia spectrum disorders: in search of a rational, evidence-informed approach

artículo científico publicado en 2013

Treatment of maladaptive aggression in youth: CERT guidelines II. Treatments and ongoing management

artículo científico publicado en 2012

Treatment of tardive dyskinesia with VMAT-2 inhibitors: a systematic review and meta-analysis of randomized controlled trials.

artículo científico publicado en 2018

Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

artículo científico publicado en 2016

Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics: A Systematic Review and Meta-analysis

artículo científico publicado en 2016

Type and duration of subsyndromal symptoms in youth with bipolar I disorder prior to their first manic episode

artículo científico publicado en 2014

Ulotaront: a TAAR1/5-HT1A agonist in clinical development for the treatment of schizophrenia

artículo científico publicado en 2022

Universal and selective interventions to promote good mental health in young people: Systematic review and meta-analysis

artículo científico publicado en 2020

Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives

artículo científico

Use of electroconvulsive therapy for Asian patients with schizophrenia (2001-2009): Trends and correlates.

artículo científico publicado en 2015

Using Long-acting Injectable Antipsychotics to Enhance the Potential for Recovery in Schizophrenia

artículo científico publicado en 2020

Validation study of the early onset schizophrenia diagnosis in the Danish Psychiatric Central Research Register

artículo científico publicado en 2018

Variants in the DRD2 locus and antipsychotic-related prolactin levels: A meta-analysis

artículo científico publicado en 2016

Vitamin D status in anorexia nervosa: A meta-analysis

artículo científico publicado en 2014

Weight gain and metabolic risks associated with antipsychotic medications in children and adolescents

artículo científico publicado en 2011

What is good mental health? A scoping review

scientific article published on 31 December 2019

What's in a Name? Moving to Neuroscience-Based Nomenclature in Pediatric Psychopharmacology

artículo científico publicado en 2018

When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature

artículo científico publicado en 2011

Which clinical and biochemical predictors should be used to screen for diabetes in patients with serious mental illness receiving antipsychotic medication? A large observational study

artículo científico publicado en 2019

Worldwide Differences in Regulations of Clozapine Use.

artículo científico publicado en 2016

ω-3 Polyunsaturated Fatty Acids to Prevent Psychosis: The Importance of Replication Studies.

artículo científico publicado en 2017

Lista de obras de Christoph Correll

100 Olanzapine/Samidorphan for Schizophrenia: Weight Gain and Metabolic Outcomes in Phase 3 ENLIGHTEN-2 and Subsequent Long-Term, Open-Label Safety Study

104 Long-term Efficacy of Lurasidone in Antipsychotic-naïve vs. Antipsychotic-exposed Adolescents with Schizophrenia: Analysis of a Two-Year Study

130. Meta-Analysis of Tardive Dyskinesia Rates in Randomized Controlled Studies Comparing First- to Second-Generation Antipsychotics.

186 Results From a 12-Month Open-label Safety Study of Lumateperone (ITI-007) in Patients with Stable Symptoms of Schizophrenia

24. The Clinical Development of Lumateperone (ITI-007) for the Treatment of Schizophrenia.

67 Effects of Long-term Valbenazine on Psychiatric Status in Patients with Tardive Dyskinesia and a Primary Mood Disorder

A Randomized Comparison of Aripiprazole and Risperidone for the Acute Treatment of First-Episode Schizophrenia and Related Disorders: 3-Month Outcomes

A Severity-Based Clinical Staging Model for the Psychosis Prodrome: Longitudinal Findings From the New York Recognition and Prevention Program

A comparative meta-analysis of TEMPS scores across mood disorder patients, their first-degree relatives, healthy controls, and other psychiatric disorders

A meta-analysis of cardio-metabolic abnormalities in drug naïve, first-episode and multi-episode patients with schizophrenia versus general population controls

A meta-analysis of temperament and character dimensions in patients with mood disorders: Comparison to healthy controls and unaffected siblings

A multicenter, randomized, double-blind, placebo-controlled, 16-week study of adjunctive aripiprazole for schizophrenia or schizoaffective disorder inadequately treated with quetiapine or risperidone monotherapy

A new class of VMAT-2 inhibitors for tardive dyskinesia.

A prospective study of hyperprolactinemia in children and adolescents treated with atypical antipsychotic agents

A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design

A randomized, double-blind, placebo-controlled proof of concept study to evaluate samidorphan in the prevention of olanzapine-induced weight gain in healthy volunteers

A review of physical activity correlates in patients with bipolar disorder

A simulations approach for meta-analysis of genetic association studies based on additive genetic model

A symptom combination predicting treatment-resistant schizophrenia - A strategy for real-world clinical practice

A systematic meta-analysis of the association of Neuregulin 1 (NRG1), D-amino acid oxidase (DAO), and DAO activator (DAOA)/G72 polymorphisms with schizophrenia

AACAP 2006 Research Forum--Advancing research in early-onset bipolar disorder: barriers and suggestions

Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference

Acanthosis nigricans during treatment with aripiprazole

Acetylcholinesterase inhibitors and memantine in bipolar disorder: A systematic review and best evidence synthesis of the efficacy and safety for multiple disease dimensions

Activating and Tranquilizing Effects of First-Time Treatment with Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Youth

Acute and maintenance effects of non-pharmacologic interventions for antipsychotic associated weight gain and metabolic abnormalities: a meta-analytic comparison of randomized controlled trials.

Adaptation of a peer based online emotional support program as an adjunct to treatment for people with schizophrenia-spectrum disorders

Adapting to the impact of COVID-19 on mental health: an international perspective

Adherence to guidelines for glucose assessment in starting second-generation antipsychotics

Adjunctive minocycline in schizophrenia: what one well-conducted study can tell us (and what it can't)

Adjunctive use of nonsteroidal anti-inflammatory drugs for schizophrenia: a meta-analytic investigation of randomized controlled trials

Altered Signaling in CB1R-5-HT2AR Heteromers in Olfactory Neuroepithelium Cells of Schizophrenia Patients is Modulated by Cannabis Use

Altered intrinsic functional brain architecture in female patients with bulimia nervosa

Ambiguous findings concerning potential advantages of depot antipsychotics: in search of clinical relevance

An International Society of Bipolar Disorders task force report: Precursors and prodromes of bipolar disorder

An open-label randomised comparison of aripiprazole, olanzapine and risperidone for the acute treatment of first-episode schizophrenia: Eight-week outcomes

Analgesic Effects of Alcohol: A Systematic Review and Meta-Analysis of Controlled Experimental Studies in Healthy Participants

Annual Research Review: Prevention of psychosis in adolescents - systematic review and meta-analysis of advances in detection, prognosis and intervention

Antipsychotic Medication Treatment Patterns in Adult Depression.

Antipsychotic Polypharmacy in Schizophrenia: Why Not?

Antipsychotic Use Trends in Youth With Autism Spectrum Disorder and/or Intellectual Disability: A Meta-Analysis.

Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials

Antipsychotic augmentation vs. monotherapy in schizophrenia: systematic review, meta-analysis and meta-regression analysis

Antipsychotic combinations vs monotherapy in schizophrenia: a meta-analysis of randomized controlled trials

Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: results from a nested case-control study

Antipsychotic drugs and obesity

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

Antipsychotic polypharmacy: A survey study of prescriber attitudes, knowledge and behavior ⬇️

Antipsychotic polypharmacy: a Japanese survey of prescribers' attitudes and rationales

Antipsychotic use and risk of life-threatening medical events: umbrella review of observational studies

Antipsychotics associated with the development of type 2 diabetes in antipsychotic-naïve schizophrenia patients

Antipsychotics for acute schizophrenia: making choices

Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials

Antipsychotics for primary alcohol dependence: a systematic review and meta-analysis of placebo-controlled trials

Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns

Appraising the effectiveness of electrical and magnetic brain stimulation techniques in acute major depressive episodes: an umbrella review of meta-analyses of randomized controlled trials

Are antipsychotics effective for the treatment of anorexia nervosa? Results from a systematic review and meta-analysis

Aripiprazole for the Treatment of Antipsychotic-Induced Hyperprolactinemia in an Adolescent Boy.

Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study

Assessing the comparative effectiveness of long-acting injectable vs. oral antipsychotic medications in the prevention of relapse provides a case study in comparative effectiveness research in psychiatry

Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies

Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain

Association between mental disorders and somatic conditions: protocol for an umbrella review

Association of Antidepressant Use With Adverse Health Outcomes: A Systematic Umbrella Review

Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophrenia

Attenuated psychotic and basic symptom characteristics in adolescents with ultra-high risk criteria for psychosis, other non-psychotic psychiatric disorders and early-onset psychosis

Atypical antipsychotics: recent research findings and applications to clinical practice: Proceedings of a symposium presented at the 29th Annual European College of Neuropsychopharmacology Congress, 19 September 2016, Vienna, Austria

Authors' reply

BDNF Val66Met polymorphism and antipsychotic-induced tardive dyskinesia occurrence and severity: a meta-analysis

Baseline Characteristics and Early Response at Week 1 Predict Treatment Outcome in Adolescents With Bipolar Manic or Mixed Episode Treated With Olanzapine: Results From a 3-Week, Randomized, Placebo-Controlled Trial.

Benign Ethnic Neutropenia and Clozapine Use: A Systematic Review of the Evidence and Treatment Recommendations

Biological treatment of acute agitation or aggression with schizophrenia or bipolar disorder in the inpatient setting

Bipolar Prodrome Symptom Scale - Abbreviated Screen for Patients: Description and validation

Blood Levels to Optimize Antipsychotic Treatment in Clinical Practice: A Joint Consensus Statement of the American Society of Clinical Psychopharmacology and the Therapeutic Drug Monitoring Task Force of the Arbeitsgemeinschaft für Neuropsychopharma

Body mass index identified as an independent predictor of psychiatric readmission.

Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis

CNR1 gene and risk of the metabolic syndrome in patients with schizophrenia

Can an early weight management program (WMP) prevent olanzapine (OLZ)-induced disturbances in body weight, blood glucose and lipid metabolism? Twenty-four- and 48-week results from a 6-month randomized trial

Can antidepressants be used to treat the schizophrenia prodrome? Results of a prospective, naturalistic treatment study of adolescents